Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Expenses
Research and development	$ 3,630,024	$ 3,662,056
General and administrative	4,514,520	4,736,440
Merger costs	1,053,697
Operating expenses	9,198,241	8,398,496
Other (income) loss
Change in fair value of derivative liabilities		(433,503)
Derivative liability issue costs		126,186
Foreign exchange loss	2,923	17,746
Interest income	(75,248)	(60,704)
Other loss (income)	(72,325)	(350,275)
Net loss for the year	9,125,916	8,048,221
Computation of basic loss per share
Net loss for the year	9,125,916	8,048,221
Series B Preferred stock dividend	8,616	80,431
Net loss for the year attributable to common stockholders	$ 9,134,532	$ 8,128,652
Basic and fully diluted loss per share	$ 0.87	$ 3.16
Basic and fully diluted weighted average number of shares	10,444,045	2,574,692